Archive: 2025/11

29 November Matthew Brown 0 Comments

Therapeutic Equivalence: Are Authorized Generics Really the Same as Brand Drugs?

Authorized generics are identical to brand-name drugs in every way except the label. Learn why they're therapeutically equivalent, how they differ from typical generics, and when to ask for them.

28 November Matthew Brown 2 Comments

How Doctors Around the World View Generic Medications

Doctors around the world view generic medications differently-based on cost, culture, and regulation. From Europe’s mandatory substitution to India’s life-saving supply chains, generics are reshaping global healthcare.

27 November Matthew Brown 3 Comments

Monoclonal Antibody Biosimilars: Examples and Clinical Uses

Monoclonal antibody biosimilars offer proven, cost-effective alternatives to expensive biologic drugs for cancer and autoimmune diseases. Learn key examples like trastuzumab and rituximab biosimilars, how they're approved, and why they're changing patient care.

26 November Matthew Brown 3 Comments

Opioid Overdose: How to Recognize the Signs, Respond in an Emergency, and Use Naloxone

Learn how to recognize opioid overdose signs, respond with naloxone, and save a life. Essential steps for bystanders, families, and anyone who wants to prevent fatal overdoses from fentanyl, heroin, or prescription opioids.

25 November Matthew Brown 7 Comments

Anticoagulants: Warfarin vs DOACs - Safety, Side Effects, and What You Need to Know

Warfarin and DOACs both prevent dangerous blood clots, but DOACs are now safer and easier for most people. Learn who should use each, how kidney function affects choice, real-world costs, and what to do if you bleed.

24 November Matthew Brown 5 Comments

Medication Safety for People with Low Vision or Hearing Loss: Practical Steps to Avoid Dangerous Errors

Medication errors are dangerously common for people with low vision or hearing loss. Learn practical, proven ways to identify pills, avoid mistakes, and demand safer labeling from pharmacies.

23 November Matthew Brown 6 Comments

Litigation in Generic Pharmaceutical Markets: How Patent Disputes Delay Affordable Medicines

Patent litigation in the generic drug market is delaying affordable medicines for millions. Learn how the Hatch-Waxman Act, Orange Book listings, and pay-for-delay deals are shaping access to life-saving drugs.

22 November Matthew Brown 8 Comments

Pharmacokinetic vs Pharmacodynamic Drug Interactions: What You Need to Know

Understand how pharmacokinetic and pharmacodynamic drug interactions affect your body differently-why one changes drug levels and the other changes your response. Learn what to watch for and how to stay safe.

21 November Matthew Brown 9 Comments

MedWatch Reporting for Generics: How Safety Data Is Collected and Why It Matters

MedWatch is the FDA's system for collecting safety reports on generic drugs. Learn how patients and providers report side effects, why manufacturer details matter, and how this data helps improve drug safety for millions.

20 November Matthew Brown 9 Comments

Heart Failure Management: From Diagnosis to Living Well

Heart failure management has transformed with new guidelines and medications. Learn how Stage A to D progression works, why quadruple therapy saves lives, and how SGLT2 inhibitors are changing outcomes-even for those without diabetes.